Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Piezo4Spine

Financiado

Piezo-driven theramesh: A revolutionary multifaceted actuator to repair the inju...

Piezo-driven theramesh: A revolutionary multifaceted actuator to repair the injured spinal cord Piezo4Spine aims to develop a novel multifactorial therapy for spinal cord injury (SCI) conceived as a disruptive platform enabling unprecedented multiscale actuation to drive functional neural repair by more accurately tackling S... ver más

31/12/2026

CSIC

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGA... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 2-3 | 552M€

Ver 7 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-12-15

HORIZON-EIC-2022-PATHFINDEROPEN-01-01: EIC Pathfinder Open 2022 Scope:You should apply to this call if you are looking for support from EIC Pathfinder Open to reali...

I+D

Cerrada hace 2 años

0% 100% 100%

7 Participantes

CSIC

1.07M€ | Lider

ACIB GMBH

224.38K€ | Participante

SERVICIO DE SALUD DE CASTILL...

621.77K€ | Participante

BLACK DROP BIODRUCKER GMBH

325.27K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PID2020-113480RB-I00 BIOIMPLANTES MAGNETICOS INTELIGENTES PARA REGENERACION NEURA... 218K€ Cerrado

MAT2016-78857-R DISEÑO Y DESARROLLO DE UN BIOMATERIAL 3D BIOACTIVO DE OXIDO... Cerrado

DREIMS DRUG-ELUTING ELECTRICAL IMPLANT TO REPAIR THE SPINAL CORD 3M€ Cerrado

PID2021-124839OA-I00 ESTRATEGIA COMBINATORIA: HIDROGELES MOVILES PARA LA MEJORA D... 127K€ Cerrado

SAF2017-83241-R BIOIMPLANTES PARA EL TRATAMIENTO DE LA ENFERMEDAD DE PARKINS... 145K€ Cerrado

PRE2019-091472 NUEVO BIOMATERIAL BIO-ACTIVO PARA LA REGENERACION DE LESIONE... 98K€ Cerrado

Duración del proyecto: 48 meses Fecha Inicio: 2022-12-15
Fecha Fin: 2026-12-31

Líder del proyecto

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGA... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 2-3 | 552M€

Presupuesto del proyecto 4M€

Descripción del proyecto Piezo4Spine aims to develop a novel multifactorial therapy for spinal cord injury (SCI) conceived as a disruptive platform enabling unprecedented multiscale actuation to drive functional neural repair by more accurately tackling SCI complexity. It originally relies on the pivotal role that mechanotransduction plays in the physiology and physiopathology of tissue and organ functions, never explored before for SCI. We will develop a 3D bioprinted mesh containing nanocarriers with therapeutic agents acting at two pivotal aspects of neural repair: mechanotransduction and inhibitory scarring using gene therapy strategies. Bioactive nanocarriers will base on cutting-edge nanoparticles whose release will be electrically triggered on-demand via wireless powering. Such 3D-theramesh offers a novel and exceptionally robust biomaterial for delivering agents at the lesion, controlling time and dose. Current advances on SCI therapies focus on rehabilitation, cell transplantation, drugs, biomaterials, and/or electrical stimulation. Although leading to partial sensory/motor recovery, chronic functional deficits limit daily living activities and shorten live expectancy in SCI patients, as they fail to promote successful axon regeneration at the lesion and awake lost functions. By a multidisciplinary consortium combining scientific, technological, clinical and industrial partners enriched by their interdisciplinarity, we envision to overcome limitations of current technologies by tackling multiple cellular targets involved in neural regeneration after SCI with a balanced combination of therapeutic interventions able to optimally promote functional recovery. These radical science-to-technology breakthroughs could enable, if successful, novel technologies and therapies for SCI and many other neural and non-neural pathologies in which some, but not necessarily all, of these targets are involved. Gender dimension will be implemented by ensuring that findings apply to society as a whole.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores